TG Therapeutics, Inc. (TGTX)
33.22
+1.71
(+5.43%)
USD |
NASDAQ |
Mar 31, 16:00
33.21
-0.01
(-0.03%)
After-Hours: 20:00
TG Therapeutics EPS Diluted (Quarterly) : 0.1446 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Precision BioSciences, Inc. | 1.004 |
| Krystal Biotech, Inc. | 1.699 |
| Amicus Therapeutics, Inc. | 0.0054 |
| Geron Corp. | -0.0467 |
| MannKind Corp. | -0.0519 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 23.04M |
| Revenue (Quarterly) | 192.57M |
| Total Expenses (Quarterly) | 169.54M |
| Enterprise Value | 5.417B |
| Gross Profit Margin (Quarterly) | 80.19% |
| Profit Margin (Quarterly) | 11.96% |
| Earnings Yield | 8.36% |
| Operating Earnings Yield | 2.30% |
| Normalized Earnings Yield | 8.363 |